NORRISTOWN, PA — MRO Corp. has announced the acquisition of Q-Centrix Corp., a recognized leader in enterprise clinical data management. This strategic move positions MRO to enhance clinical data exchange capabilities across the healthcare ecosystem, benefiting providers, payers, life sciences, and other clinical data users. Financial details of the transaction were not disclosed.
The combined company will serve over 2,000 hospitals and health systems, more than 7,000 clinics, and nearly 250 payers. By integrating MRO’s expertise in clinical data exchange with Q-Centrix’s advanced data management capabilities, the partnership aims to address the rising demand for enriched, actionable clinical data.
“At MRO, we believe there is tremendous untapped value in unlocking and leveraging clinical data that resides in fragmented, siloed systems today,” said Jason Brown, CEO of MRO. “Combining MRO’s leading clinical data exchange solutions and Q-Centrix’s clinical data management capabilities creates a category-defining, fit-for-purpose platform, enabling high fidelity, low latency acquisition, abstraction, curation, and exchange of clinical data to power better patient care and reduce costs across the healthcare ecosystem.”
The enhanced platform will transform raw clinical records into curated, usable data assets, simplifying complex systems, accelerating decisions, and driving better outcomes in patient care, operational performance, and research initiatives.
“MRO and Q-Centrix share a commitment to advancing the industry in service of our customers,” said Milton Silva-Craig, CEO of Q-Centrix. “That focus is fueling the creation of a first-of-its-kind platform—seamlessly integrating systems and delivering structured, highly valuable data sets to support clinical care, operational performance, breakthrough research, and regulatory compliance. Purpose-built around our customers’ most pressing needs, this is innovation where it matters most.”
The acquisition is backed by Parthenon Capital, an existing investor in MRO. Parthenon provided a new investment to accelerate the combined company’s growth. Q-Centrix is being acquired from TPG Growth, the middle market and growth equity arm of TPG, a global alternative asset management firm.
With this acquisition, MRO and Q-Centrix are poised to redefine clinical data exchange and management, allowing healthcare stakeholders to unlock more value from their data and deliver improved care outcomes.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.